Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for depo medroxyprogesterone acetate (compound)
Most Correlated Studies
- Cervical gene expression profiles in late pregnant dams treated with MPA
- Endometrial stromal cells with KLF9/PGR-knockdown and treated with 8-bromo-cAMP, estradiol, and MPA
- Breast cancer ZR-75-1 cells treated with treated with combinations of estrogen and androgen
- Human uterine fibroblast cells (HUF86P4) with or without NOTCH1 shRNA treated with EPC
- Term decidual cells, estradiol and medroxyprogesterone acetate (MPA) treated with or without IL-1B
Most Relevant Literature
- Cumulative recurrence rates of endometriosis-associated pain after long-term intramuscular depot med…
- The contraceptive depot medroxyprogesterone acetate impairs mycobacterial control and inhibits cytok…
- Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age.
- Depot medroxyprogesterone acetate use is not associated with risk of incident sexually transmitted i…
- Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vagi…
Most Relevant Clinical Trials
- Randomized Control Trial Copper Intrauterine Device and Depo-medroxyprogesterone Acetate (DMPA) of H…
- Effect of Pre-operative Depo Medroxyprogesterone Acetate on Serum Anti-mullerian Hormone Level After…
- Self Administration of Subcutaneous Depot Medroxyprogesterone Acetate
- Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer
- Acceptability of Depo-subQ in Uniject
